SIIFIC is a Signatory to the Operating Principles for Impact Management (OPIM). Recognised globally as a leading standard for impact investing, OPIM provides a structured framework for investment organisations to design, manage and assess impact in a systematic and disciplined manner. As a Signatory, SIIFIC is part of a global community of investors advancing and learning from best practices in impact management.
All Signatories are required to publish an annual Disclosure Statement describing how each of the nine Principles is integrated into their investment processes, and to undertake periodic independent verification to confirm alignment with the Principles.In line with these requirements, SIIFIC publishes the following documents:

SIIFIC is a Founding Adopter of the Impact Performance Reporting Norms established by Impact Frontiers.
We prepare our Impact Performance Report in accordance with these Norms, which are internationally recognised as a global standard for impact investing reporting and provide a robust framework for transparent, consistent disclosure of impact results. In line with this commitment, SIIFIC makes the following reports publicly available:

SIIFIC is a Signatory to the Impact Investment Initiative for Global Health (Triple I), an international coalition launched following its endorsement at the G7 Hiroshima Summit in 2023 and formally established during the UN General Assembly’s High-Level Meetings later that year. Triple I aims to mobilise private capital for global health and to promote sustainable financing, raising awareness of impact investing in health, facilitating cross-sector collaboration, and supporting transparent impact measurement, evaluation and reporting across its member organisations.SIIFIC is also featured as a case study in Triple I’s Global Health Impact Measurement and Management Practitioner Guide, a widely referenced resource that provides practical methodologies for impact measurement and management in the global health field.
As a Signatory, SIIFIC is committed to these objectives and aligns its global-health investment efforts with Triple I’s standards and collaborative framework.